The Quantellect read.As of Nov 19, 2026, 17 active firms cover CVS Health Corp: 17 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $94.00 to $125.00, so the covering firms are broadly aligned. The average target of $112.00 sits 38% above the current $81.26. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.74 next quarter toward $8.70 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Buy
Strong Buy00%
Buy17100%
Neutral00%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$112.00
+37.8% upside
Average target across 17 active firms as of Nov 19, 2026 vs $81.26 current
Highest Target$125.00
Average Target$112.00
Lowest Target$94.00
Detailed analyst forecasts for CVS
Showing 1–17 of 17 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 17 of 17 active firms rate CVS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CVS EPS & revenue forecast
EPS · NEXT QUARTER
$2.74
Range $2.53 – $2.93 · 13 analysts · +6% YoY
Next period, 13 analysts expect CVS Health Corp to earn $2.74 a share (range $2.53 – $2.93), versus $2.57 a year earlier. Full-year consensus is $8.28, growing to $8.70 the year after.
REVENUE · NEXT QUARTER
$102.1B
Range $97.9B – $104.4B · 13 analysts · +2% YoY
Revenue is expected to reach $102.1B (range $97.9B – $104.4B), +1.7% year-over-year. Full-year consensus is $421.9B, rising to $431.2B next year.
Top analysts covering CVS Health Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CVS.
#1
Stephen Baxter
Wells Fargo · Rank #63
Buy
$123.00+51.4% to target
Overall win rate
47%
+ Follow
#2
Erin Wright
Morgan Stanley · Rank #81
Buy
$111.00+36.6% to target
Overall win rate
55%
+ Follow
#3
DM
David Macdonald
Truist Securities · Rank #111
Buy
$118.00+45.2% to target
Overall win rate
50%
+ Follow
#4
Ben Hendrix
RBC Capital · Rank #150
Buy
$113.00+39.1% to target
Overall win rate
44%
+ Follow
#5
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$110.00+35.4% to target
Overall win rate
37%
+ Follow
CVS stock forecast FAQ
What is CVS's average 12-month price target?+
The 17 active firms with a live target average $112.00 for CVS Health Corp over the next 12 months, ranging from a $125.00 high to a $94.00 low, as of Nov 19, 2026.
Is CVS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 17 active firms as of Nov 19, 2026, 17 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CVS?+
The Street-high target is $125.00 (Evercore ISI Group), and the Street-low is $94.00 (Baird). The average of all 17 active-firm targets is $112.00.
How many active Wall Street firms cover CVS?+
17 active firms have a recognized rating on CVS Health Corp as of Nov 19, 2026, and 17 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CVS?+
Among analysts who currently cover CVS, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Buy with a $123.00 target.
What is CVS Health Corp's projected EPS for next quarter?+
The consensus estimate is $2.74 per share (range $2.53 – $2.93) across 13 analysts. Full-year EPS is projected at $8.28, rising to $8.70 the following year.
How much revenue is CVS Health Corp expected to report next quarter?+
Consensus revenue is $102.1B (range $97.9B – $104.4B). Full-year revenue is projected at $421.9B, growing to $431.2B next year.
Have analysts been upgrading or downgrading CVS lately?+
As of Nov 19, 2026, 17 of 17 active firms rate CVS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CVS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.